When MoCRA was signed into law in December 2022, most cosmetics importers shrugged. By the time enforcement actually started in mid-2024, most non-US brands had registered their manufacturing facilities and called it done. Eighteen months later, we're catching the same three mistakes on almost every detention at EWR and LAX.2022 年 12 月 MoCRA 签署立法时，大多数化妆品进口商没当回事。2024 年中执法真正开始时，多数非美品牌已经完成了工厂注册，就觉得万事大吉。一年半过去了，我们在 EWR 和 LAX 几乎每一起扣货都看到同样的三个漏洞。
This piece is for cosmetics brands selling on Amazon US, Shopify US, or to brick-and-mortar US retail. It is not legal advice. It is what we tell our customers when they call us at 11pm with a held container.这篇写给在亚马逊美国、Shopify 美国或美国线下零售卖货的化妆品品牌。这不是法律意见，是我们在客户晚上 11 点甩着扣货通知打电话来时告诉他们的内容。
1. What MoCRA actually is1. MoCRA 到底是什么
MoCRA — the Modernization of Cosmetics Regulation Act of 2022 — is the first significant expansion of FDA authority over cosmetics since 1938. It made four big things mandatory:MoCRA（2022 年化妆品监管现代化法案）是自 1938 年以来 FDA 对化妆品监管权限的第一次显著扩大。它把以下四件事变为强制要求：
- Facility registration — every facility manufacturing or processing cosmetics distributed in the US.工厂注册 —— 所有在美销售的化妆品制造 / 加工工厂。
- Product listing — every cosmetic product, listed with FDA, refreshed at least annually.产品列名 —— 每一款化妆品产品向 FDA 列名，至少年度更新。
- Responsible Person — a US-based person or entity legally responsible for the product's safety and labeling.责任人 —— 一个对产品安全与标签合规承担法律责任的美国本地个人或实体。
- Adverse event recordkeeping — six-year retention; reports of serious adverse events submitted within 15 business days.不良事件记录 —— 保留 6 年；严重不良事件需在 15 个工作日内报告。
If you only remember one thing: facility registration is not enough. By itself, it is the equivalent of registering your car and never putting plates on it.如果只能记住一件事：工厂注册不够。仅做工厂注册相当于"上了车牌登记但没挂车牌"。
2. The three things people miss2. 最容易漏的三件事
a) Product listinga) 产品列名
Facility registration tells the FDA where your stuff is made. Product listing tells them what you're making. The two are independent. We routinely meet brands with 30–80 SKUs in active US distribution but zero listed products.工厂注册告诉 FDA 你的货在哪里生产，产品列名告诉 FDA 你具体生产了什么。两者独立。我们经常遇到品牌有 30–80 个 SKU 在美国正常销售，但列名数为零。
Each product listing requires: brand name, product category code (FDA assigns these), ingredient list in descending order by weight, image of the labeling, manufacturer / Responsible Person details, and discontinuation flag. None of it is hard; all of it has to be there.每条产品列名要包含：品牌名、产品类目代码（FDA 指定）、按重量降序的成分表、标签图、生产商 / 责任人信息、停产标记。每一项都不难，但都必须有。
b) Responsible Person designationb) 责任人指派
The Responsible Person (RP) must be a US-based entity. Most non-US brands haven't designated one — or have designated their US Agent without realizing the two are legally distinct roles with different liability profiles.责任人（Responsible Person, RP）必须是美国本地实体。大多数非美品牌没有指派，或者错把美国代理人当成了责任人 —— 这是两个法律责任不同的角色。
A US Agent represents you to FDA for communications. A Responsible Person bears legal responsibility for the product's safety, labeling, and adverse-event reporting. The same entity can play both roles, but you must designate each explicitly. We've seen multiple holds where the brand had a US Agent but no listed RP.美国代理人代表你与 FDA 沟通；责任人承担产品安全、标签合规、不良事件报告的法律责任。同一实体可同时担任两角色，但必须分别明确指派。我们见过不止一起扣货是品牌有美国代理人但责任人未列。
c) Adverse event recordsc) 不良事件记录
Most brands haven't set up the system. Records must be retained six years; serious adverse events (hospitalization, disfigurement, etc.) reported within 15 business days. The FDA can request records at any time. "We don't have a system" is not an acceptable answer.大多数品牌还没搭这个系统。记录必须保留 6 年；严重不良事件（住院、毁容等）需在 15 个工作日内上报。FDA 可在任何时候调取记录。"我们没有这个系统"不是可接受答复。
3. Enforcement status (May 2026)3. 执法现状（2026 年 5 月）
From our 18 months of FDA hold data:基于我们 18 个月 FDA 扣货数据：
| Quarter季度 | MoCRA-flagged holdsMoCRA 扣货 | Most common cause最常见原因 | Avg release time平均放行时长 |
|---|---|---|---|
| 2024 Q3 | 3 | Facility not registered | 6 d |
| 2024 Q4 | 7 | Facility OK, no product listing | 9 d |
| 2025 Q1 | 11 | No RP designated | 10 d |
| 2025 Q2 | 14 | No RP / labeling mismatch | 11 d |
| 2025 Q3 | 16 | Labeling claim violation | 12 d |
| 2025 Q4 | 13 | Labeling + adverse event records | 9 d |
// A redacted Notice of Action — what arrives when MoCRA paperwork is incomplete.// 经遮罩的 Notice of Action 文件 —— MoCRA 文件不全时你会收到的就是这个。
Pattern: enforcement broadened from "do you exist at all" in 2024 Q3 to "does your labeling claim line up with your listing" by 2025 Q4. That last bucket is hardest to fix because it involves reprinting, not paperwork.趋势：执法从 2024 Q3 的"你到底有没有注册"扩展到 2025 Q4 的"你的标签声明是否与列名一致"。最后这一类最难处理，因为涉及重印而不是补文件。
4. Three remediation paths4. 三条整改路径
Path A: Fix at origin, before next shipment路径 A：起运前在工厂端修
If your next shipment hasn't left yet: do product listing first (we typically clear listings within 5–10 business days), designate an RP (we can act as RP under engagement), and update labeling for the next print run. Cost: low. Time: 2–4 weeks. Risk: lowest.如果下一票货还没起运：先做产品列名（我们通常 5–10 个工作日完成）、指派责任人（我们可在合作协议下担任）、并在下一次印刷前更新标签。成本：低。时间：2–4 周。风险：最低。
Path B: In-transit triage路径 B：在途分流
If your shipment is already at sea or in the air: file Prior Notice with the corrected listing details, designate RP, and prepare the labeling discrepancy explanation packet for CBP. This works only if labeling itself is compliant — paperwork can be filed in parallel with transit. Cost: medium. Time: aligned with transit. Risk: medium.如果货已经在船上 / 飞机上：用正确列名信息申报 Prior Notice，指派责任人，并准备好标签差异说明材料供 CBP 调取。前提是标签本身合规——文件可以并行处理。成本：中。时间：与运输同步。风险：中。
Path C: Reconditioning at US warehouse路径 C：在美仓整改
If your shipment is already held: submit a reconditioning plan to FDA, recondition at a US warehouse with bonded zone (we use our SAV node), and request release. Typically 8–14 days from FDA acceptance to release. Cost: highest. Time: 1–3 weeks. Risk: meaningful but recoverable.如果货已经被扣：向 FDA 提交整改方案，在带保税区的美仓做整改（我们用 SAV 节点），申请放行。一般 FDA 受理后 8–14 天放行。成本：最高。时间：1–3 周。风险：可观但可恢复。
Re-export should be your absolute last resort. We've seen brands re-export $40k+ worth of inventory when a $3–6k reconditioning would have released it. The default for many forwarders is to recommend re-export because it ends their problem fastest — not yours.退运应是最后选项。我们见过品牌为了"快速结束麻烦"退运了价值 $40k+ 的库存——而当时一个 $3–6k 的整改就能放行。很多货代默认建议退运，因为这样他们的问题最快结束——但不是你的。
5. What we recommend5. 我们的建议
If you're reading this and your brand sells cosmetics into the US:如果你正在读这篇，并且你的品牌在向美国卖化妆品：
- Check your FDA
FCEIS/CDRaccount: confirm facility registration is active AND every active SKU has a listing record.登录 FDA 的FCEIS/CDR账户：确认工厂注册有效，且每一个在销 SKU 都有列名记录。 - Verify there is one explicitly designated Responsible Person of record, and that the RP's name is on your labeling.确认有一个明确备案的责任人，并且责任人名字印在你的标签上。
- Set up an adverse-event intake form even if you've had zero events — having the system documented is part of compliance.即便从未发生不良事件，也要建立不良事件登记表 —— 流程文档本身就是合规的一部分。
- When in doubt, get a 30-minute pre-assessment from an RA team that actually files for a living, not a freight forwarder doing it on the side.不确定时，找一个真正以申报为主业的法规事务团队做 30 分钟预评估，不要找把"顺便代办"的货代。
Our team has done this for 60+ MoCRA-regulated brands since 2024. If you'd like a free 30-minute pre-assessment, the link is below.自 2024 年起，我们的团队已为 60+ MoCRA 监管品牌完成相关申报。如需 30 分钟免费预评估，链接见下。